School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China.
Front Public Health. 2023 Aug 7;11:1211976. doi: 10.3389/fpubh.2023.1211976. eCollection 2023.
Vaccination is a compelling measure to battle infectious diseases and protect public health. However, because of the constraints on human cognition, it is difficult to ensure that vaccines are safe. Adverse reactions to immunization can cause individual injury. In numerous countries, no-fault programs have been established to compensate individuals for vaccine-related injuries. China also established a vaccine injury compensation system with its own unique characteristics. The Vaccine Administration Law was promulgated in 2019 to establish a compensation system for those who experience adverse reactions following immunization; nevertheless, the compensation system is imperfect. Even when the applicable terms are applied to deal with vaccine-related injuries, some issues remain, such as unreasonable diagnosis and evaluation procedures for adverse reactions, excessively strict standards regarding proof and inconsistent compensation standards across the country. Therefore, to provide effective compensation for vaccine recipients, it is important to clarify the standards of proof and establish a sensible vaccine injury compensation system that includes Corona Virus Disease 2019 vaccine-injury compensation.
疫苗接种是应对传染病和保护公众健康的有力措施。然而，由于人类认知的限制，很难确保疫苗的安全性。免疫接种的不良反应会导致个体受伤。在许多国家，都建立了无过错计划，以赔偿因疫苗相关伤害的个人。中国也建立了具有自身特色的疫苗损害赔偿制度。2019 年颁布了《疫苗管理法》，为接种后出现不良反应的人建立了赔偿制度；然而，该赔偿制度并不完善。即使在适用条款来处理疫苗相关伤害时，也存在一些问题，例如不良反应的诊断和评估程序不合理、证明标准过于严格以及全国赔偿标准不一致。因此，为了为疫苗接种者提供有效的赔偿，明确证明标准并建立合理的疫苗损害赔偿制度，包括新冠病毒病 2019 疫苗损害赔偿制度，是很重要的。
